(Q44281134)

1 December 2017

title

A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome (English)

1 reference

1 December 2017

1 reference

Okada M

1

1 reference

1 December 2017

Nishimura H

2

1 reference

1 December 2017

Kawashima M

3

1 reference

1 December 2017

Okabe N

4

1 reference

1 December 2017

Maeda K

5

1 reference

1 December 2017

Seo M

6

1 reference

1 December 2017

Ohkuma K

7

1 reference

1 December 2017

Takata T

8

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Alimentary Pharmacology & Therapeutics

1 December 2017

published in

1 reference

1 December 2017

volume

13

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

769-774

1 reference

Antimicrobial therapy for Helicobacter pylori infection

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

A reliable cure for Helicobacter pylori infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients. A personal viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

One-week triple therapy with lansoprazole, clarithromycin, and metronidazole to cure Helicobacter pylori infection in peptic ulcer disease in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Resistance of Helicobacter pylori to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.1999.00551.X

10.1046/J.1365-2036.1999.00551.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference